Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Lifestyle Modification Program to Reduce Risk of Coronary Heart Disease in Latina Women With Diabetes
This study is ongoing, but not recruiting participants.
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00233259
  Purpose

The Latina Lifestyle Program (LLP) will comprehensively evaluate a multiple risk factor intervention (diet, physical activity, stress management, social support, and smoking cessation) in a randomized effectiveness trial, which will be offered in English and Spanish to diabetic Latinas.


Condition Intervention
Cardiovascular Diseases
Heart Diseases
Diabetes Mellitus, Type 2
Behavioral: Mediterranean Diet
Behavioral: Physical Activity
Behavioral: Stress Management
Behavioral: Social Support
Behavioral: Smoking Cessation
Other: Control group

MedlinePlus related topics: Diabetes Heart Disease in Women Heart Diseases Quitting Smoking Smoking
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Open Label, Parallel Assignment, Efficacy Study
Official Title: CHD Lifestyle Modification for Latinas With Diabetes

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Primary Outcome Measures:
  • Adherence to the Mediterranean Diet, physical activity, stress management, and smoking cessation protocols [ Time Frame: Measured at baseline, 6, 12, and 24 months ] [ Designated as safety issue: No ]
  • Hemoglobin A1c [ Time Frame: Measured at baseline, 6, 12, and 24 months ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Social support [ Time Frame: Measured at baseline, 6, 12, and 24 months ] [ Designated as safety issue: No ]

Estimated Enrollment: 300
Study Start Date: March 2006
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: July 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Active Comparator
Multiple risk factor intervention, that will include diet, physical activity, stress management, social support, and smoking cessation components
Behavioral: Mediterranean Diet
Mediterranean dietary program
Behavioral: Physical Activity
Physical activity program
Behavioral: Stress Management
Stress management program
Behavioral: Social Support
Social support
Behavioral: Smoking Cessation
Smoking cessation program
2: Placebo Comparator
Control group
Other: Control group
Control group

Detailed Description:

BACKGROUND:

Age-adjusted mortality from coronary heart disease (CHD) has been increasing in women with diabetes. On the other hand, it has been decreasing in women without diabetes and in men with and without diabetes. CHD remains the leading cause of death among women in the United States. Risks of CHD and resulting death are significantly higher among postmenopausal women; these rates are two and a half times higher among women with diabetes versus women without diabetes. Diabetes is an independent risk factor for CHD in both Latina and Anglo women, but it appears to be a greater risk factor for U.S. born Latinas, as they have higher mortality from diabetes. Among Latinas, diabetes ranks as the third leading cause of death.

DESIGN NARRATIVE:

Hispanic Americans, in particular postmenopausal Hispanic women, have an increased prevalence of type 2 diabetes, and a greater incidence of diabetes complications than non-Hispanic whites. The LLP will comprehensively evaluate a multiple risk factor intervention (diet, physical activity, stress management, social support, and smoking cessation) in a randomized effectiveness trial that will be offered in English and Spanish. The research team has shown that a similar theory-based comprehensive program, Mediterranean Lifestyle Program (MLP), is effective in improving behavioral, psychosocial, quality of life, and physiologic outcomes in postmenopausal Anglo women with type 2 diabetes. Though the results are promising, four important research issues must be addressed before such a program is ready to be put into practice. This study focuses on the following questions: 1) How should the structure and content of the MLP be modified to address the cultural characteristics of Latinas?; 2) Will the program succeed if offered within a large health plan that serves minority populations (i.e., the Kaiser Permanente site in Denver, CO)?; and 3) What are the economic implications of the LLP? The Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) evaluation framework will be used to assess how the program impacts certain dimensions that are important for carry over into clinical practice. Primary outcomes of this study will include change in behavioral measures. Secondary outcomes will include impacts on quality of life, physiologic measures, member satisfaction, and cost-effectiveness. The investigators will also study the relationship between cultural variables in this Hispanic population (e.g., family and social support; group cohesion; and acculturation) and program participation and outcomes. Substantial impacts of this study on public health include: 1) intervening with a high-risk, underserved population; 2) focusing on multiple critically important lifestyle behaviors known to reduce risk for CHD; 3) testing maintenance of behavioral changes; 4) employing methodology to estimate the program's readiness to be put into practice; and (5) measuring the robustness, reach, and cost-effectiveness of the program.

  Eligibility

Ages Eligible for Study:   45 Years to 75 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Type 2 diabetes
  • Postmenopausal
  • Latina

Exclusion criteria:

  • Cognitive impairment or inability to comprehend program
  • Has other life-threatening illnesses
  • Planning to move from the area during the study
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00233259

Locations
United States, Colorado
Institute for Health Research
Denver, Colorado, United States, 80237
Sponsors and Collaborators
Investigators
Study Chair: Deborah J. Toobert, PhD Oregon Research Institute
  More Information

Responsible Party: Oregon Research Institute ( Deborah J. Toobert, PhD )
Study ID Numbers: 327, R01 HL76151
Study First Received: October 3, 2005
Last Updated: July 28, 2008
ClinicalTrials.gov Identifier: NCT00233259  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Heart Diseases
Metabolic Diseases
Myocardial Ischemia
Diabetes Mellitus
Vascular Diseases
Endocrine System Diseases
Ischemia
Coronary Disease
Diabetes Mellitus, Type 2
Endocrinopathy
Glucose Metabolism Disorders
Metabolic disorder
Coronary Artery Disease

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 16, 2009